Ansan, Discovery Lab, Titan deal

ANSN will merge with privately held Discovery Laboratories, a developer of drugs to treat critical respiratory conditions. ANSN plans to issue common shares in the transaction. In

Read the full 279 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE